Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Simone Incicco, Salvatore Piano

Clin Mol Hepatol. 2024;30(4):695-697. Published online June 3, 2024

DOI: https://doi.org/10.3350/cmh.2024.0409

View: 1288 Download: 30 Web of Science: 1 Crossref: 1

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2022;28(2):273-275. Published online February 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0036

View: 6957 Download: 242 Web of Science: 3 Crossref: 3

Maria Buti, Juan Carlos Ruiz-Cobo, Rafael Esteban, Mar Riveiro-Barciela

Received September 5, 2024 Accepted November 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0758 [Accepted]

View: 721 Download: 77

1 |

Viewed By 6343	MAFLD: How is it different from NAFLD?
Viewed By 5382	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5095	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4190	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 3981	Gut microbiome and metabolome signatures in liver cirrhosis-related complications

Cited By 272	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 230	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 156	MAFLD: How is it different from NAFLD?
Cited By 79	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 76	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search